• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GoodRx and Iodine Merge Quietly to Bring Transparency to Drug Pricing

by Jasmine Pennic 01/30/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

GoodRx And Iodine Merge Quietly to Bring Transparency to Drug PricingGoodRx, a Santa Monica, CA-based startup that compares retail prices of prescription drugs from different pharmacies in the United States has quietly merged with San Francisco-based startup Iodine, FastCompany first reports. The merger was not announced publicly, but Iodine CEO Thomas Goetz confirmed the deal took place at the end of 2016. Financial terms of the merger were not disclosed.

Founded in 2013, Iodine mines clinical data to help consumers make better decisions about their medications. The company aggregates open government datasets (FDA, CMS, VA) to create targeted, actionable tools that drive better decisions, better adherence, and better outcomes. The company has raised $2.5M in funding to date and landed a $1.5M contract with the Food and Drug Administration (FDA) to build the openFDA project in 2015 to make publicly available FDA data sets more accessible and useful to developers.

Prescription drug prices often vary significantly across pharmacies, making it difficult for a patient to select the least costly option. Co-founded by Scott Marlette and Doug Hirsch, both early employees of Facebook in 2011, GoodRx saves all Americans – the uninsured, underinsured and insured – over 80 percent on their prescriptions by helping them make more informed purchasing decisions.

GoodRx and Iodine initially started working together in 2016 to integrate its drug-pricing data into Iodine’s existing content. The founders of both companies have a shared vision to enhance the consumer experience for drug pricing and medications.

As part of the merger, Iodine will continue to operate with the same team and will not relocate to GoodRx’s headquarters.  According to Goetz, the merger will help consumers to make better choices and bring transparency to drug pricing. “People are being exposed to very expensive prices for drugs and they don’t understand why,” Goetz says.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GoodRx, Healthcare Mergers & Acquisitions, Iodine

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |